Comparative Analysis of Chitosan, Lipid Nanoparticles, and Alum Adjuvants in Recombinant SARS-CoV-2 Vaccine: An Evaluation of Their Immunogenicity and Serological Efficacy

ABSTRACT:

SUBMITTER: Ghattas M 

PROVIDER: S-EPMC12390328 | biostudies-literature | 2025 Jul

REPOSITORIES: biostudies-literature